Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Nagao · SciRah

Researcher profile · Semantic Scholar

S. Nagao

Share profile

S. Nagao — researcher profile on SciRah

h-index: 25
Works: 120
Citations: 3,573

Most-cited papers

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
I. Ray-Coquard, P. Pautier, S. Pignata, D. Pérol +26 more
2019New England Journal of Medicine1,702 citations Open access
Semantic Scholar
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.
I. Ray-Coquard, A. Leary, S. Pignata, C. Cropet +26 more
2023Annals of Oncology357 citations Open access
Semantic Scholar
Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group
A. Kojima, M. Shimada, Y. Mikami, S. Nagao +6 more
2017International Journal of Gynecologic Cancer91 citations Open access
Semantic Scholar
Applicability of the concept of "platinum sensitivity" to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup study.
S. Nagao, S. Nishio, H. Michimae, H. Tanabe +6 more
2013Gynecologic Oncology77 citations
Semantic Scholar
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.
S. Labidi-Galy, M. Rodrigues, J. L. Sandoval, J. Kurtz +16 more
2022Annals of Oncology66 citations Open access
Semantic Scholar
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix
K. Hasegawa, S. Nagao, M. Yasuda, D. Millan +11 more
2014International Journal of Gynecologic Cancer60 citations Open access
Semantic Scholar
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition
S. Nagase, Y. Inoue, N. Umesaki, D. Aoki +30 more
2010International Journal of Clinical Oncology53 citations
Semantic Scholar
A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer.
K. Fujiwara, E. Aotani, T. Hamano, S. Nagao +7 more
2011Japanese Journal of Clinical Oncology39 citations
Semantic Scholar
Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study)
Kazuto Nakamura, Yoshikazu Kitahara, T. Satoh, Yuji Takei +4 more
2016World Journal of Surgical Oncology37 citations Open access
Semantic Scholar
Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
Kazuhiro Suzuki, S. Nagao, T. Shibutani, Kasumi Yamamoto +6 more
2019Gynecologic Oncology33 citations
Semantic Scholar
Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
Kasumi Yamamoto, S. Nagao, Kazuhiro Suzuki, A. Kogiku +6 more
2017Gynecologic Oncology33 citations
Semantic Scholar
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
E. Miyagi, Noriaki Arakawa, K. Sakamaki, N. Yokota +10 more
2021International Journal of Clinical Oncology31 citations Open access
Semantic Scholar
Intraperitoneal Carboplatin for Ovarian Cancer - A Phase 2/3 Trial.
S. Nagao, K. Fujiwara, Kouji Yamamoto, H. Tanabe +25 more
2023NEJM Evidence30 citations Open access
Semantic Scholar
Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review
S. Nagao, M. Miwa, N. Maeda, A. Kogiku +8 more
2015International Journal of Gynecologic Cancer30 citations Open access
Semantic Scholar
Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)
K. Matsusaki, Kuniaki Aridome, S. Emoto, H. Kajiyama +7 more
2021International Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy
K. Fujiwara, K. Hasegawa, S. Nagao
2019Cancer27 citations
Semantic Scholar
Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy
T. Hanaoka, K. Hasegawa, Tomomi Kato, Sho Sato +6 more
2017Molecular Diagnosis & Therapy27 citations
Semantic Scholar
Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer
K. Hasegawa, Y. Ikeda, Yuko Kunugi, A. Kurosaki +8 more
2018Journal of immunotherapy25 citations
Semantic Scholar
Phase II Study of Combination Chemotherapy With Docetaxel and Carboplatin for Locally Advanced or Recurrent Cervical Cancer
S. Takekida, K. Fujiwara, S. Nagao, S. Yamaguchi +5 more
2010International Journal of Gynecologic Cancer25 citations
Semantic Scholar
Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer: A Sankai Gynecology Cancer Study Group Study
K. Fujiwara, S. Nagao, J. Kigawa, J. Noma +5 more
2009International Journal of Gynecologic Cancer25 citations Open access
Semantic Scholar
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer
Y. Kajimoto, K. Honda, Shiro Suzuki, M. Mori +12 more
2023International Journal of Clinical Oncology23 citations
Semantic Scholar
Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix
M. Shimada, S. Nagao, K. Fujiwara, N. Takeshima +6 more
2016International Journal of Clinical Oncology23 citations
Semantic Scholar
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
K. Matsuo, J. Cripe, K. Kurnit, M. Kaneda +48 more
2019Gynecologic Oncology21 citations Open access
Semantic Scholar
Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study
M. Tanioka, S. Yamaguchi, M. Shimada, S. Nagao +6 more
2017Medical Oncology20 citations
Semantic Scholar
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study
S. Nagao, S. Nishio, S. Okada, Takeo Otsuki +13 more
2015Cancer Chemotherapy and Pharmacology18 citations
Semantic Scholar
A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Akemi Morimoto, S. Nagao, A. Kogiku, Kasumi Yamamoto +6 more
2016Japanese Journal of Clinical Oncology16 citations
Semantic Scholar
Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer
Y. Kajimoto, T. Shibutani, S. Nagao, S. Yamaguchi +12 more
2022International Journal of Gynecological Cancer14 citations Open access
Semantic Scholar
Correlation between pre-operative and final histological diagnosis on endometrial cancer
T. Shiozaki, M. Miwa, Toshiko Sakuma, Kazuhiro Suzuki +9 more
2019International Journal of Gynecologic Cancer14 citations Open access
Semantic Scholar
Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer
K. Fujiwara, S. Nagao, E. Aotani, K. Hasegawa
2013Expert Opinion on Pharmacotherapy14 citations
Semantic Scholar
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
K. Takehara, Takashi Matsumoto, J. Hamanishi, K. Hasegawa +14 more
2021Journal of Gynecologic Oncology12 citations Open access
Semantic Scholar
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
K. Fujiwara, H. Fujiwara, H. Yoshida, T. Satoh +13 more
2021Journal of Gynecologic Oncology11 citations Open access
Semantic Scholar
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
S. Nagao, A. Kogiku, Kazuhiro Suzuki, T. Shibutani +6 more
2020Journal of Ovarian Research11 citations Open access
Semantic Scholar
Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer
S. Nagao, Kasumi Yamamoto, T. Oishi, S. Yamaguchi +3 more
2020International Journal of Clinical Oncology11 citations
Semantic Scholar
Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy
M. Takekuma, Fumiaki Takahashi, S. Mabuchi, Wataru Kudaka +16 more
2020BMC Cancer11 citations Open access
Semantic Scholar
Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial
M. Mizuno, Kimihiko Ito, H. Nakai, H. Kato +17 more
2022International Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
T. Shibutani, S. Nagao, Kazuhiro Suzuki, M. Kaneda +8 more
2019International Journal of Clinical Oncology10 citations
Semantic Scholar
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)
H. Fujiwara, K. Ushijima, S. Nagao, Yuji Takei +16 more
2019International Journal of Clinical Oncology10 citations
Semantic Scholar
Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma: A Feasibility Study
S. Nagao, Norihiro Iwasa, A. Kurosaki, T. Nishikawa +4 more
2012International Journal of Gynecologic Cancer10 citations Open access
Semantic Scholar
Leptomeningeal metastases arising from gynecological cancers
H. Yano, S. Nagao, S. Yamaguchi
2019International Journal of Clinical Oncology9 citations
Semantic Scholar
Effect of prior olaparib maintenance therapy for platinum sensitive recurrent ovarian cancer on response to subsequent platinum‐based chemotherapy
H. Nakazawa, S. Nagao, M. Narita, T. Shibutani +5 more
2022The journal of obstetrics and gynaecology research8 citations
Semantic Scholar
Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study
Kasumi Yamamoto, S. Nagao, Tomoharu Tsu, T. Matsushima +11 more
2021The journal of obstetrics and gynaecology research8 citations
Semantic Scholar
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma
Kazuhiro Suzuki, S. Nagao, M. Narita, H. Nakazawa +8 more
2021International Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Single nedaplatin treatment as salvage chemotherapy for platinum/taxane‐resistant/refractory epithelial ovarian, tubal and peritoneal cancers
T. Goto, M. Takano, R. Ohishi, Norihiro Iwasa +4 more
2010The journal of obstetrics and gynaecology research8 citations
Semantic Scholar
The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin
S. Nagao, Norihiro Iwasa, A. Kurosaki, T. Nishikawa +3 more
2015International Journal of Gynecologic Cancer6 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
S. Nagao, J. Tamura, T. Shibutani, M. Miwa +10 more
2023International Journal of Clinical Oncology5 citations Open access
Semantic Scholar
A randomized phase 3 trial of intraperitoneal versus intravenous carboplatin with dose-dense weekly paclitaxel in patients with ovarian, fallopian tube, or primary peritoneal carcinoma (a GOTIC-001/JGOG-3019/GCIG, iPocc Trial) (LBA 3)
K. Fujiwara, S. Nagao, Kouji Yamamoto, H. Tanabe +22 more
2022Gynecologic Oncology5 citations
Semantic Scholar
Effects of treatment by temsirolimus on patients with clear cell carcinoma of the ovary.
Y. Kikuchi, K. Kudoh, M. Takano, R. Kikuchi +6 more
20105 citations
Semantic Scholar
Successful Endoscopic Treatment for High-grade Cervical Intraepithelial Neoplasia with Gross Lesions of the Vagina
Koyo Yamamoto, M. Kitai, Kasumi Yamamoto, Toshiko Sakuma +2 more
2021Gynecology and Minimally Invasive Therapy4 citations Open access
Semantic Scholar
Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis
T. Shibutani, S. Nagao, Kazuhiro Suzuki, Kasumi Yamamoto +5 more
2021The journal of obstetrics and gynaecology research4 citations
Semantic Scholar
Diagnosis of desmoplastic small‐round‐cell tumor by cytogenetic analysis: a case report
Senn Wakahashi, T. Sudo, Kotaro Ichida, S. Sugita +5 more
2016Clinical Case Reports4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Yamaguchi×22
Invite
S. Yamaguchi — researcher profile on SciRah
K. Fujiwara×21
Invite
K. Fujiwara — researcher profile on SciRah
K. Hasegawa×12
Invite
K. Hasegawa — researcher profile on SciRah
Kasumi Yamamoto×12
Invite
Kasumi Yamamoto — researcher profile on SciRah

×10

Invite

J. Kigawa — researcher profile on SciRah

T. Shibutani×10

Invite

T. Shibutani — researcher profile on SciRah

Invite

M. Kitai — researcher profile on SciRah

Invite

H. Yano — researcher profile on SciRah

Invite

T. Shiozaki — researcher profile on SciRah

Kazuhiro Suzuki×8

Invite

Kazuhiro Suzuki — researcher profile on SciRah

Invite

T. Jimi — researcher profile on SciRah

Invite

K. Matsuoka — researcher profile on SciRah